The subcutaneous formulation of LEQEMBI offers at-home administration, simplifying treatment for Alzheimer's patients and potentially boosting adherence. The in-vitro diagnostic could aid in early diagnosis, supporting timely treatment.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing